Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Annual Review of Pharmacology and Toxicology
|
October 13, 2016
Targeted Protein Degradation by Small Molecules
Daniel P Bondeson, Craig M Crews
Methods in Molecular Biology (Clifton, N.J.)
|
August 25, 2021
An In Vitro Pull-down Assay of the E3 Ligase:PROTAC:Substrate Ternary Complex to Identify Effective PROTACs
Daniel P Bondeson, Blake E Smith, Alexandru D Buhimschi
Chemical Communications (Cambridge, England)
|
June 11, 2020
Scaffold hopping enables direct access to more potent PROTACs with in vivo activity
George M Burslem, Daniel P Bondeson, Craig M Crews
Cancer Research
|
July 18, 2019
Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation
George M Burslem, Anna Reister Schultz, Daniel P Bondeson, et al.
American Journal of Physiology. Renal Physiology
|
September 21, 2012
In vivo Drosophilia genetic model for calcium oxalate nephrolithiasis
Taku Hirata, Pablo Cabrero, Donald S Berkholz, et al.
Journal of Insect Physiology
|
February 11, 2012
Ion and solute transport by Prestin in Drosophila and Anopheles
Taku Hirata, Anna Czapar, Lauren Brin, et al.
Cell Chemical Biology
|
November 14, 2017
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
Daniel P Bondeson, Blake E Smith, George M Burslem, et al.
Cell Chemical Biology
|
November 14, 2017
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study
George M Burslem, Blake E Smith, Ashton C Lai, et al.
Nature Communications
|
September 20, 2022
Systematic profiling of conditional degron tag technologies for target validation studies
Daniel P Bondeson, Zachary Mullin-Bernstein, Sydney Oliver, et al.
Nature Chemical Biology
|
June 16, 2015
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P Bondeson, Alina Mares, Ian E D Smith, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Annual Review of Pharmacology and Toxicology
|
October 13, 2016
Targeted Protein Degradation by Small Molecules
Daniel P Bondeson, Craig M Crews
Methods in Molecular Biology (Clifton, N.J.)
|
August 25, 2021
An In Vitro Pull-down Assay of the E3 Ligase:PROTAC:Substrate Ternary Complex to Identify Effective PROTACs
Daniel P Bondeson, Blake E Smith, Alexandru D Buhimschi
Chemical Communications (Cambridge, England)
|
June 11, 2020
Scaffold hopping enables direct access to more potent PROTACs with in vivo activity
George M Burslem, Daniel P Bondeson, Craig M Crews
Cancer Research
|
July 18, 2019
Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation
George M Burslem, Anna Reister Schultz, Daniel P Bondeson, et al.
American Journal of Physiology. Renal Physiology
|
September 21, 2012
In vivo Drosophilia genetic model for calcium oxalate nephrolithiasis
Taku Hirata, Pablo Cabrero, Donald S Berkholz, et al.
Journal of Insect Physiology
|
February 11, 2012
Ion and solute transport by Prestin in Drosophila and Anopheles
Taku Hirata, Anna Czapar, Lauren Brin, et al.
Cell Chemical Biology
|
November 14, 2017
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
Daniel P Bondeson, Blake E Smith, George M Burslem, et al.
Cell Chemical Biology
|
November 14, 2017
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study
George M Burslem, Blake E Smith, Ashton C Lai, et al.
Nature Communications
|
September 20, 2022
Systematic profiling of conditional degron tag technologies for target validation studies
Daniel P Bondeson, Zachary Mullin-Bernstein, Sydney Oliver, et al.
Nature Chemical Biology
|
June 16, 2015
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P Bondeson, Alina Mares, Ian E D Smith, et al.
Page
of 2